Viewpoints » Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby

09/15/2022Viewpoint

Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby

Patients can now get results from PCR tests the same day thanks to new testing choices like Visby.

Visby Tech in the Deep South: How an Alabama Urgent Care is Using Visby

The Visby Sexual Health Test was showcased during local news coverage on an urgent care clinic located in Madison County, Alabama. The ApproXie Urgent Care clinic was the talk of the county thanks to their recent switch to the Visby Medical test for Sexual Health, which according to the columnist provides “results faster than ever before.”

Mackenzie Romero, the director of practice management, was reported as saying, “It definitely helps in diagnosing. We’re able to treat the patients much faster when we know what they test positive for.”

For the 20 people a week that turn to ApproXie Urgent Care for STD testing, the prospect of shorter wait times can mean peace of mind — no more waiting multiple days for results.

In reference to the 2.5 million total reported cases of chlamydia, gonorrhea and syphilis reported in 2021 Director of Clinical Operations, Haven Brolsma said, “Especially since 2017, there’s been a rise, and with the pandemic of COVID, it has increasingly gotten higher. Some patients don’t even have symptoms.”

According to WAAY31 TV ABC, “The CDC recommends STD testing at least once a year, which in the past could take up to a week for results. With new testing options at ApproXie Urgent Care, patients get results the same day.”

We couldn’t have said it better.

Learn more about Visby here.

Reference article:  Madison County clinic offering new STD test with results in 30 minutes (Author: Nicole Zedeck, Sep 9, 2022 Updated Sep 10, 2022; waaytv.com)

Read more articles & insights

02/21/2024Press Release

CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million to develop a portable polymerase chain reaction (PCR) test that can detect gonorrhea and assess its susceptibility to ciprofloxacin.

Read More
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

12/01/2023Viewpoint

Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

As the chill in the air intensifies, healthcare systems worldwide brace themselves for a seasonal upswing in respiratory illnesses. This year, the situation is exacerbated by the continuing threat of COVID-19 alongside the potential resurgence of seasonal influenza (Flu A and Flu B).

Read More
Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

11/18/2023Viewpoint

A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

In the setting of a global pandemic, the specter of SARS-CoV-2 infection has understandably dominated the differential diagnosis for respiratory symptoms. However, it is crucial to remember that other respiratory pathogens continue to circulate, potentially leading to varied clinical presentations in patients who share the same exposure or living environment.

Read More
A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

05/11/2023Viewpoint

Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Read More
Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected